, Tracking Stock Market Picks
Enter Symbol:
Amylin Pharmaceuticals, Inc. (AMLN) [hlAlert]

down 11.73 %

Amylin Pharmaceuticals, Inc. (AMLN) rated Underperform by BMO Capital Markets

Posted on: Thursday,  Mar 4, 2010  8:25 AM ET by BMO Capital Markets

BMO Capital Markets rated Underperform Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) on 03/04/2010. Previously BMO Capital Markets rated Underperform Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN)
on 04/22/2008., when the stock price was $27.31. Since then, Amylin Pharmaceuticals, Inc. has gained 13.29% as of 08/06/2012's recent price of $30.94.
If you would have followed the previous BMO Capital Markets's recommendation on AMLN, you would have lost 11.73% of your investment in 1567 days.

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN injection and BYETTA injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego, California with over one thousand five hundred employees nationwide.

The U.S. Equity Research team comprises over 25 analysts located in New York, Atlanta, Boston, Denver, Houston and Los Angeles. We cover more than 375 stocks and also provide equity strategy, quantitative analysis and portfolio management services to our clients. Our goal is to identify the best sectors to invest in, and the best stocks within those sectors, in order to help our clients maximize their portfolio returns. Our award-winning analysts provide research that is informative, perceptive and actionable.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/4/2010 8:25 AM Sell
as of 12/31/2010
1 Week up  0.59 %
1 Month down  -17.23 %
3 Months up  27.91 %
1 YTD down  -5.91 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/22/2008 8:25 AM Sell
1/29/2008 10:25 AM Hold
30.09 34.00
10/18/2007 9:25 AM Hold
45.69 44.00
9/28/2007 11:25 AM Hold
50.00 47.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy